Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 1/20 | 0.43 |
| ▸ | PRF1 | P14222 | 6/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | APP | P05067 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.34 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.34 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | DPP4 | P27487 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21706474 | 0.93 | PRF1 (0.42) | PGRPRF1MAPTAPPCYP2A6 | |
| SCHEMBL20044280 | 0.88 | PGR (0.35) | PGRPRF1MAPTAPPCYP2C9 | |
| SCHEMBL20365628 | 0.87 | PGR (0.42) | PGRPRF1MAPTAPPCYP2A6 | |
| SCHEMBL23278536 | 0.82 | PRF1 (0.43) | PGRPRF1MAPTAPPCYP2A6 | |
| SCHEMBL20247154 | 0.79 | PGR (0.32) | PGRPRF1 | |
| SCHEMBL20246959 | 0.77 | PGR (0.35) | PGRPRF1MAPTKDM4EALDH1A1 | |
| SCHEMBL21949336 | 0.77 | PGR (0.35) | PGRPRF1MAPTKDM4EALDH1A1 | |
| SCHEMBL9538845 | 0.76 | APP (0.54) | PGRPRF1MAPTAPPCYP2A6 | |
| SCHEMBL21709685 | 0.76 | KMT2A (0.35) | PRF1MAPTAPPHPGDALDH1A1 | |
| SCHEMBL20043832 | 0.76 | RAB9A (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11183637-B2 | Organic photodetector | Raynergy Tek Incorporation (TW) | 2021-11-23 | — | — | US | disclosed |
| US-10759775-B2 | Organic semiconducting compounds | MERCK PATENT GMBH (DE) | 2020-09-01 | — | — | US | disclosed |
| US-20200052216-A1 | ORGANIC PHOTODETECTOR | MERCK PATENT GMBH (DE) | 2020-02-13 | — | — | US | disclosed |
| WO-2018065352-A1 | ORGANIC PHOTODETECTOR | MERCK PATENT GMBH (DE) | 2018-04-12 | — | — | WO | disclosed |
| WO-2018065356-A1 | ORGANIC SEMICONDUCTING COMPOUNDS | MERCK PATENT GMBH (DE) | 2018-04-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10759775-B2 | Organic semiconducting compounds | OCIAD2, OCIAD1, OSTC | PGR 1261/4885PRF1 3118/4885MAPT 46/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.